WINNING STRATEGIES WASHINGTON for NOVARTIS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2012 | $40,000 | Replaced |
| 2nd Quarter - Amendment | Oct 4, 2012 | $40,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY13 Department of Defense Appropriations Orphan drugs and tax issues PDUFA
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Health Issues HCR
Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and progress of the deficit reduction committee
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.